Features of MR Imaging that Differentiate between Immunohistochemically Diagnosed Dedifferentiated Liposarcoma and...

This study aimed to compare the differences in the imaging findings for dedifferentiated liposarcoma (DDLS) and myxoid liposarcoma (MLS).

The study included 30 patients with histopathologically confirmed DDLS and 13 patients with MLS. All DDLSs and MLSs were diagnosed immunohistochemically using MDM2 and DDIT3 staining, respectively. Conventional MRI, CT, and ¹⁸F-fluorodeoxyglucose-positron emission tomography/CT findings were retrospectively evaluated and compared between the 2 pathologies.

The median age of patients with DDLS was higher than that of patients with MLS (74 vs. 46 years, P < 0.01). In 10 DDLSs and 7 MLSs with fatty areas, the well-differentiated liposarcoma-like fatty areas were more common in DDLS than in MLS (70% vs. 14%), whereas septal/linear fatty areas were less common in DDLS than in MLS (30% vs. 86%, P < 0.05). The T2-hyperintense area of non-fatty area was less common in DDLS than in MLS (50% vs. 92%, P < 0.05), and the tumor-to-muscle signal intensity ratio of non-fatty areas on T2-weighted images was lower in DDLS than in MLS (3.18 vs. 5.92, P < 0.01). Apparent diffusion coefficient value was lower in DDLS than in MLS (1.29 vs. 2.10 × 10^-3mm²/sec, P < 0.01). Unenhanced CT attenuation of non-fatty area was greater in DDLS than in MLS (33 vs. 19 Hounsfield unit, P < 0.01).

MRI features are valuable in differentiating MLS from DDLS. Younger age, septal/linear fatty areas, and high signal intensity of non-fatty areas on T2-weighted images were useful for diagnosing MLS.